Prevention of Fatty Liver in Transition Dairy Cows by Subcutaneous Injections of Glucagon
- 1 May 2006
- journal article
- research article
- Published by American Dairy Science Association in Journal of Dairy Science
- Vol. 89 (5) , 1533-1545
Abstract
The main objective of this study was to test the extent to which injecting glucagon subcutaneously for 14 d beginning at d 2 postpartum would prevent fatty liver development in transition dairy cows. Twenty-four multiparous Holstein cows were fed 6 kg of cracked corn in addition to their standard diet during the last 30 d of a dry period to induce postpartum development of fatty liver. Glucagon at either 7.5 or 15 mg/d or saline (control) was injected subcutaneously 3 times daily for 14 d beginning at d 2 postpartum. Glucagon at 15 mg/ d prevented liver triacylglycerol accumulation in postpartum dairy cows. Glucagon at 7.5 mg/d showed potential for fatty liver prevention. Glucagon increased concentration of plasma glucose and insulin and decreased plasma nonesterified fatty acid concentrations. No effects of glucagon were detected on plasma beta-hydroxybutyrate concentrations. Glucagon affected neither feed intake nor milk production. Moreover, milk composition was not altered by glucagon. Milk urea N concentrations decreased, and plasma urea N concentrations tended to decrease during glucagon administration, indicating that glucagon may improve protein use. Liver glycogen concentrations were not affected by glucagon. No significant differences in body condition scores were detected among treatments throughout the study. These results indicate that subcutaneous glucagon injections can prevent fatty liver in transition dairy cows without causing major production and metabolite disturbances.Keywords
Funding Information
- U.S. Department of Agriculture (99-35005-8576)
This publication has 54 references indexed in Scilit:
- Monitoring and testing dairy herds for metabolic diseaseVeterinary Clinics of North America: Food Animal Practice, 2004
- Metabolic changes in early lactation and impaired reproductive performance in dairy cowsVeterinary Research, 2003
- The Coactivator PGC-1 Is Involved in the Regulation of the Liver Carnitine Palmitoyltransferase I Gene Expression by cAMP in Combination with HNF4α and cAMP-response Element-binding Protein (CREB)Journal of Biological Chemistry, 2002
- Action of Glucagon and Glucagon-Like Peptide-1-(7-36) Amide on Lipolysis in Human Subcutaneous Adipose Tissue and Skeletal Muscle in VivoThe Journal of Clinical Endocrinology & Metabolism, 2001
- New Aspects of Ketone Bodies in Energy Metabolism of Dairy Cows: A ReviewJournal of Veterinary Medicine Series A, 1996
- Physiological Effect of Glucagon in Human Isolated AdipocytesHormone and Metabolic Research, 1995
- Regulation of free fatty acid metabolism by glucagonThe Journal of Clinical Endocrinology & Metabolism, 1993
- Glucose Stimulation of the Antilipolytic Effect of Insulin in HumansScience, 1983
- A new enzymatic method for determination of serum choline-containing phospholipidsClinica Chimica Acta, 1977
- Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogenJournal of Clinical Pathology, 1969